Rhinocerebral mucormycosis with orosinusal involvement: Diagnostic and surgical treatment guidelines

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 16, Issue 4, 2016, Pages 264-269

  Giudice, Giuseppe ^a   Cutrignelli, Daniela Anna ^a   Sportelli, Pasquale ^a   Limongelli, Luisa ^b   Tempesta, Angela ^b   Di Gioia, Giuseppe ^a   Santacroce, Luigi ^b   Maiorano, Eugenio ^b   Favia, Gianfranco ^b  

^a Department of Emergency and Organ Transplantation Complex Operating Unit of Plastic and Reconstructive Surgery ^*  (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Immunocompromised patients; Mucorales; Rhinocerebral mucormycosis; Sinusitis; Surgical debridement; Zygomycetes

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; IODINE; POSACONAZOLE; AMPHOTERICIN B;

ADULT; ARTICLE; BONE NECROSIS; BONE RESECTION; BRAIN ABSCESS; CASE REPORT; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DRUG DOSE INCREASE; ENDOSCOPY; FACE PAIN; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MIDDLE AGED; MUCORMYCOSIS; NORMAL HUMAN; NOSE DISCHARGE; NOSE DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OROSINUSAL MUCORMYCOSIS; OSTEOLYSIS; PANORAMIC RADIOGRAPHY; PERIODONTAL DISEASE; PIEZOELECTRICITY; PRACTICE GUIDELINE; RHINOCEREBRAL MUCORMYCOSIS; RHINOENDOSCOPY; SCHOOL CHILD; THREE DIMENSIONAL IMAGING; ANTIBIOTIC PROPHYLAXIS; INFECTIOUS ENCEPHALITIS; PATHOLOGY; PREOPERATIVE CARE; RHINITIS;

ADULT; AMPHOTERICIN B; ANTIBIOTIC PROPHYLAXIS; BRAIN ABSCESS; CHILD; FEMALE; HUMANS; INFECTIOUS ENCEPHALITIS; MALE; MIDDLE AGED; MUCORMYCOSIS; PRACTICE GUIDELINES AS TOPIC; PREOPERATIVE CARE; RHINITIS;

EID: 85013817143     PISSN: 18715303     EISSN: 22123873     Source Type: Journal    
DOI: 10.2174/1871530316666161223145055     Document Type: Article

References (21)

1. Ciesla, M.C.; Kammeyer, P.L.; Yeldandi, V.; Petruzzelli, G.J.; Yong, S.L. Identification of the asexual state of Rhizopus species on histologic tissue sections in a patient with rhinocerebral mucormycosis. Arch. Pathol. Lab. Med., 2000, 124, 883-887.
2. Ribeiro, N.F.F.; Cousin, G.C.S.; Wilson, G.E.; Butterworth, D.M.; Woodwards, R.T. Lethal invasive mucormycosis: case report and recommendations for treatment. Int. J. Oral Maxillofac. Surg., 2001, 30(2), 156-159.
3. Pillsbury, H.C.; Fischer, N.D. Rhinocerebral mucormycosis. Arch. Otolaryngol., 1977, 103, 600-604.
4. Doni, B.R.; Peerapur, B.V.; Thotappa, L.H.; Hippargi, S.B. Sequence of oral manifestations in rhino-maxillary mucormycosis. Ind. J. Dent. Res., 2011, 22, 331-335.
5. Harril, W.C.; Stewart, M.G.; Lee, A.G.; Cernoch, P. Chronic rhinocerebral mucormycosis. Laryngoscope, 1996, 106, 1292-1297.
6. Blitzer, A.; Lawson, W.; Meyers, B.R.; Biller, H.F. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope, 1980, 90, 635-648.
7. Gamba, J.L.; Woodruff W.W.; Djang, W.T.; Yeates, A.E. Craniofacial mucormycosis: Assessment with CT. Radiology, 1986, 160, 207.
8. O’Neill, B.M.; Alessi, A.S. George, E.B.; Piro, J. Disseminated Rhinocerebral mucormycosis: a case report and review of the literature. J. Oral Maxillofac. Surg., 2006, 64(2), 326-333.
9. Schwartz, J.N.; Donnelly, E.H.; Klintworth, G.K. Ocular and orbital phycomycosis. Surv. Ophthalmol., 1977, 22, 3-28.
10. Prasad, K.; Lalitha, R.M.; Reddy, E.K.; Ranganath, K.; Srinivas, D.R.; Singh, J. Role of Early Diagnosis and Multimodal Treatment in Rhinocerebral Mucormycosis: Experience of 4 Cases. J. Oral Maxillofac. Surg., 2012, 70, 354-362.
11. Walsh, T.J.; Hiemenz, J.W.; Seibel, N.L.; Perfect, J.R.; Horwith, G.; Lee, L.; Silber, J.L.; DiNubile, M.J. Reboli, A.; Bow, E.; Lister, J.; Anaissie, E.J. Amphotericin B lipid complex for invasive fungal infection: Analysis of safety and efficacy in 556 cases. Clin. Infect. Dis., 1998, 26, 1383-1396.
12. Walsh, T.J.; Goodman, J.L.; Pappas, P.; Bekersky, I.; Buell, D.N.; Roden, M., Barrett, J.; Anaissie, E.J. Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tollerate dose study. Antimicrob. Agents Chemoter., 2001, 45, 3487-3496.
13. Brazzola, P.; Rossi, M.R. High weekly doses of liposomal amphotericin B a secondary prophylaxis after cerebral aspergillosis in a paediatric patient. Med. Mycol., 2014, 3, 1-3.
14. Walsh, T.J.; Kontoyiannis, D.P. Editorial commentary: What is the role of combination therapy in management of zygomycosis? Clin. Infect. Dis., 2008, 47, 372-374.
15. Talmi, Y.P.; Goldschmied-Reouven, A.; Bakon, M.; Barshack, I.; Wolf, M.; Horowitz, Z.; Berkowicz, M.; Keller, N.; Kronenberg, J. Rhino-orbital and rhino-orbito-cerebral mucormycosis. Otolaryngol. Head Neck Surg., 2002, 127, 22-31.
16. Kohn, R.; Hepler, R. Management of limited rhino-orbital mucormycosis without exenteration. Ophthalmology, 1985, 92, 1440-1444
17. Epstein, V.; Kern, R. Invasive fungal rhinosinusitis and complications of rhinosinusitis. Otolaryngol. Clin. North. Am., 2008, 41, 497-524.
18. Parfrey, N.A. Improved diagnosis and prognosis of mucormycosis: A clinicopathologic study of 33 cases. Medicine, 1986, 65(2), 113-123.
19. Tyson, J.; Gittelman, P.D.; Jacobs, J.B.; Holliday, R. Press R: Recurrent mucormycosis of the paranasal sinuses in an immunologically competent host. Otolaryngol. Head Neck Surg., 1992, 107, 115-119.
20. Ribes, J.A.; Vanover-Sams, C.L.; Baker, D.J. Zygomycetes in human disease. Clin Microbiol. Rev., 2000, 13(2), 236-301.
21. Singh, V.; Sharma, B.; Sen, R.; Agrawal, S.; Bhagol, A.; Bali, R. Rhinocerebral mucormycosis: a diagnostic challenge and therapeutic dilemma in immunocompetent host. J. Oral Maxillofac. Surg., 2012, 70, 1369-1375.